You have read all your free articles, to continue reading subscribe to read the rest of this content.
Recipharm has equipped its sixth facility with serialisation capabilities before the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 miAlready a subscriber Login You have…
AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe and Russia to Cheplapharm. Seroquel and Seroquel XR, used primarily to treat schizophrenia and bipolar disorderAlready a subscriber Login You have read all your…
This dual listing will further enable the advance its two innovative programs: CDNF in Parkinson’s Disease and drug candidate, Lymfactin, in Lymphedema. As part of the offering Herantis issued a total of 618,018 new shares at a price of €6.72 EUR / SEK 71 per share bringing the total number…
Novo Nordisk has entered into a definitive agreement to acquire Emisphere Technologies, a drug delivery company with technologies such as the Eligen SNAC technology, that enable oral formulations of therapeutics. Novo Nordisk and Emisphere have collaborated since 2007 and Emisphere’s drug delivAlready a subscriber Login You have read all your…
